Home » BU Spinout AllegroDx to Launch Array-Based Lung Cancer Test This Year

BU Spinout AllegroDx to Launch Array-Based Lung Cancer Test This Year

Jan 05, 2010
Premium

By Justin Petrone

Allegro Diagnostics later this year plans to begin marketing a microarray-based test for early-stage lung cancer, according to CEO Dan Rippy.

Get the full story with
GenomeWeb Premium

Only $95 for the
first 90 days*

A trial upgrade to GenomeWeb Premium gives you full site access, interest-based email alerts, access to archives, and more. Never miss another important industry story.

Try GenomeWeb Premium now.

Already a GenomeWeb Premium member? Login Now.
Or, See if your institution qualifies for premium access.

*Before your trial expires, we’ll put together a custom quote with your long-term premium options.

Not ready for premium?

Register for Free Content
You can still register for access to our free content.

The Scan

DNA Defense Not Convincing

Two researchers have found that behavioral genetic defenses in criminal cases don't tend to affect outcomes, according to Popular Science.

Keep on Brushing

Researchers report that while host genetics influence the oral microbiome, they don't appear to affect cavity-causing microbes, the Economist says.

Panda Gut Seasonality

Pandas' gut microbiomes change as what they eat changes with the seasons, writes Discover's Inkfish blog.

This Week in PLOS

In PLOS this week: comparative genomic study of malaria-linked macaque parasite, search for apple root reference genes, and more.

What's Popular?

In Microarrays & Multiplexing

  1. Researchers Identify SNP Set, Develop QR Code to Distinguish Genome Samples

  2. RNA-Editing Protein ADAR Promotes Progression of Lung Cancer, New Study Finds

Sponsorships

Privacy Policy.  Copyright © 2017 GenomeWeb LLC.  All Rights Reserved.